Company: STAA
Filing Date: 2025-10-02
Form Type: DFAN14A
Source: 0001213900-25-095514
Chunk: 17

Company: STAAR SURGICAL CO
Filing Date: 2025-10-02
Form: DFAN14A
Chunk 17
---
 growth.” 1 May 7, 2025 Cost Reductions of at least $25M The Board believed that STAAR’s stock represented an attractive investment opportunity and that the intrinsic value of the Company was meaningfully higher “Our decision to initiate a share repurchase program underscores the Board’s and management’s confidence in STAAR’s future and our ability to return to sustainable, profitable growth … With a strong balance sheet, no debt, and clear progress in our cost optimization and strategic priorities, we are well - positioned to capitalize on opportunities ahead.” 2 May 16, 2025 $30M Share Repurchase Program The Board seemingly saw opportunities to create incremental value through improved capital allocation and empaneled a dedicated committee to refine the Company’s capital strategies “ Capital allocation is a key focus for STAAR given our growth prospects, strong cash flow generation, and opportunities to drive long - term value from our propriety Collamer® material.” 3 June 25, 2025 Formation of Capital Stewardship Committee 1 B

Broadwood Partners, L.P. Year - Over - Year Net Sales Growth 1 LTM Net Sales at End of Period ($M) 1 Markets Outside China Remain Robust… 25 Sales in the Americas and EMEA have continued to grow consistently and show no signs of slowing ▪ While sales in China have been depressed as distributors have been working off excess channel inventory, STAAR’s sales in the Americas and EMEA regions have continued to grow ▪ Management expects sales in the U.S. to accelerate as surgeons gain confidence with the EVO ICL procedure and patients have positive experiences 3 ▪ STAAR’s growth in the U.S. continues to outpace the U.S. refractive market more broadly “by a large margin” 3 ▪ EMEA sales exceeded management’s initial outlook and STAAR expects to continue to benefit from investments in this important market 1,3 ▪ STAAR’s European distributor markets, as well as Spain and the Middle East, have remained resilient and delivered growth, even in the face of a dynamic geopolitical backdrop and elevated inflation levels 3 12% 12% 11% 21% 8% 10% 11% 5% 4% 22% 16% 11% 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 Americas EMEA $23 $24 $24 $25 $26 $26 $40 $41 $41